A detailed history of Trust Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trust Asset Management LLC holds 3,828 shares of MRNA stock, worth $141,061. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,828
Previous 3,828 -0.0%
Holding current value
$141,061
Previous $454,000 43.83%
% of portfolio
0.02%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $13,294 - $19,307
-98 Reduced 2.5%
3,828 $587,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $26,683 - $43,884
226 Added 6.11%
3,926 $464,000
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $20,966 - $31,609
179 Added 5.08%
3,700 $529,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $20,739 - $38,548
164 Added 4.89%
3,521 $607,000
Q3 2021

Oct 29, 2021

BUY
$221.9 - $484.47 $744,918 - $1.63 Million
3,357 New
3,357 $1.29 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Trust Asset Management LLC Portfolio

Follow Trust Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trust Asset Management LLC with notifications on news.